StockData
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Inc (LBRX) stock

LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.30−2.69 (-6.26%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

LB Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

LB Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$82.40M. For fiscal 2025 it was -$35.21M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$35.21M–
FY2024Dec 31, 2024-$53.05M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$37.63M–
Q1 FY2026Mar 31, 2026-$23.29M–
Q4 FY2025Dec 31, 2025-$18.10M–
Q3 FY2025Sep 30, 2025-$3.37M–
Q2 FY2025Jun 30, 2025-$5.60M–
Q1 FY2025Mar 31, 2025-$8.13M–
Q4 FY2024Dec 31, 2024-$5.67M–

More LB Pharmaceuticals figures

See a number that looks wrong?